The future of biotechnology testing in the next decade: a perspective

The power of genomics in transforming the biotechnology industry will be evident in all areas of drug discovery and development. This will be particularly true in safety evaluation, where the field will be forced to adapt to new schemes of e-R&D and e-business in general. Toxicologists will be required to create information-rich, real-time systems that can be used for decisions in the earliest phases of discovery and throughout development. The largest growth area in specific product types will be those that can move genomics information from the laboratory to the clinic the fastest.